The global sulphonamides market is estimated to grow at a CAGR of nearly 4.0% during the forecast period. Increasing prevalence of urinary tract infection and skin infection is the major factor contributing to the growth of the market. As per the World Health Organization (WHO), urinary tract infection (UTI) is the major cause of morbidity and healthcare spending among all age group individuals. An estimated 40%-50% of women witnessed having UTI at some point in their lives. Significant rise in the elderly population is one of the causes leading to an increased prevalence of UTIs. As per the United Nations (UN), by 2050, one in six people globally will be more than the age of 65 (16%), increased from one in 11 in 2019 (9%).

Get Free Sample Copy @https://www.omrglobal.com/request-sample/sulphonamides-market

UTIs are considered as common concerns ins the ageing population. The condition ranges from relatively benign cystitis to potentially severe pyelonephritis. An aged person suffering from mental difficulties are observed for other UTI signs, including bloody urine, pressure in the lower pelvis, and pain or burning with urination. UTIs may occur either due to the pathogenicity of the organism, the susceptibility of the host or a combination of both factors. Antimicrobials, including Sulfonamides, nalidixic acid, and trimethoprim-sulfamethoxazole are commonly used for the treatment of UTIs.

Browse for Full Report Description@https://www.omrglobal.com/industry-reports/sulphonamides-market

These medications are useful to treat uncomplicated lower and acute UTIs in an outpatient environment. Sulphonamides have a wide range of antimicrobial activity against several microorganisms such as bacteria and some protozoa including plasmodia and toxoplasma. Currently, they are normally used in combination with other agents including pyrimethamine and trimethoprim to treat parasitic diseases. The main parasitic causes of UTIs include leishmaniasis, filariasis, schistosomiasis, and trichomoniasis. Therefore, it is expected that sulphonamides have significant applications in the treatment of UTIs, which in turn, is encouraging the market growth.

Market Segmentation

Global Sulphonamides Market by Route of Administration

Oral
Topical
Global Sulphonamides Market by Application

Urinary Tract Infection
Skin Infection
Eye Infection
Respiratory Tract Infection
Gastrointestinal Tract Infection
Others
Regional Analysis

North America

United States
Canada
Europe

UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific

China
India
Japan
Rest of Asia-Pacific
Rest of the World

Company Profiles

AA Pharma Inc.
Abbott Laboratories
Allergan plc
Bausch Health Companies Inc.
Bayer AG
Boehringer Ingelheim International GmbH
Cipla Ltd.
DK Pharmachem Pvt. Ltd.
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Lexine Technochem Pvt. Ltd.
Mylan N.V.
Pfizer Inc.
Prudence Pharma Chem
Teva Pharmaceutical Industries Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/sulphonamides-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404